Clinical Activity of a Polyvalent Melanoma Antigen Vaccine-Reference-Cited by-同舟云学术

Clinical Activity of a Polyvalent Melanoma Antigen Vaccine

Published:1995 Issue: Volume: Page:337-348
ISSN:0080-0015
Container-title:Recent Results in Cancer Research
language:
Short-container-title:

Author:

Bystryn J.-C.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-78771-3_26.pdf

Reference18 articles.

1. Adler A, Oratz R, Liebes L, Bystryn J-C (1990) Effect of allogeneic melanoma vaccine on the in vitro cellular immune response. Proc Am Assoc Cancer Res 31:252

2. Balch CM, Soong S-J, Shaw HM (1985) A comparison of world-wide melanoma data. In: Shaw HM, Seng-Jaw S (eds) Cutaneous melanoma. Lippincott, Philadelphia, pp 507–518

3. Berdeaux DH, Meyskens FL Jr, Parks B et al (1989) Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease. Cancer 63:1430–1436

4. Bystryn J-C (1978) Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma associated antigens. J Immunol 120:96–101

5. Bystryn J-C (1990) Tumor vaccines. Cancer Metastasis Rev 9:81–91

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines;Human Vaccines & Immunotherapeutics;2023-01-02

2. Novel dendritic cell-based vaccination in late stage melanoma;Human Vaccines & Immunotherapeutics;2014-11

3. Therapy of Melanoma;The Melanocytic Proliferations;2014-01-17

4. Jean-Claude Bystryn 1938-2010. An obituary;Experimental Dermatology;2010-11-02

5. Immunotherapy for Melanoma: Current Status and Perspectives;Journal of Immunotherapy;2010-07